MedTrace Logo

Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload

NCT02833493 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-07-14

No results posted yet for this study

Summary

The investigators aim to give an overview of Iron overload(IOL) of patients with AA and low and int-1 risk MDS and their sequelae under different chelation treatment. And the investigators also aim to evaluate the relationship of LIC and T2\*/R2\*.

Conditions

  • Aplastic Anemia
  • Dysmyelopoietic Syndromes
  • Iron Overload

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-09-30
Completion
2019-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02833493 on ClinicalTrials.gov